This section contains information summarizing Part D plan sponsor responsibilities regarding fraud, waste, and abuse in the Prescription Drug Program and provides an overview of CMS reporting requirements.
Part D Reporting Requirements
Final Part D reporting requirements are posted in the downloads section of this page.
Click the selection that best matches your information needs. Please check back, as we will continue to update these resources regularly.
Downloads
-
CY2022_Part D Reporting Requirements_012022 (PDF) -
CY2022 Technical Specifications_060222 (PDF) -
2021 Bene-Level MTMP Submission Instructions (12212021) (PDF) -
CY2021 Part D Reporting Requirements 120920 (PDF) -
CY 2021 Technical Specifications 11252020 (PDF) -
2020 Bene-Level MTMP Submission Instructions (12312020) (PDF) -
CY2020_Part D Reporting Requirements_082719 (PDF) -
Updated CY 2020 Technical Specifications_111920 (PDF) -
2019 Bene-level MTMP Submission Instructions_UPDATE_01282020 (PDF) -
CY2019_Part D Reporting Requirements_08022018 (PDF) -
CY2019 Technical Specifications_030619 (PDF) -
2018 MTM Submission Instructions Memo (12312018) (PDF) -
CY2018_Part D Reporting Requirements 12072017 (PDF) -
CY2018 Technical Specifications_010418 (PDF) -
2017 MTM Submission Instructions Memo (12212017) (PDF) -
CY2017_Part D Reporting Requirements 02232017 (PDF) -
CY2017 Technical Specifications_103017 (PDF) -
CY2016_Part D Reporting Requirements 06092016 (PDF) -
CY2016 Technical Specifications_082516 (PDF) -
CY2015_Part D Reporting Requirements_FINAL_012015 (PDF) -
CY2015 Technical Specifications_092115 (PDF) -
CY14 Part D Reporting Requirements (V02.25.14) (PDF) -
CY2014 Technical Specifications_102014 v2 (PDF)